CN Patent

CN101268099A — 用于治疗性干预的y4选择性受体激动剂

Assigned to 7TM Pharma AS · Expires 2008-09-17 · 18y expired

What this patent protects

本说明书中所述的选自下组的Y4受体激动剂肽：[Ala30]PP 2－36 ，[Thr30]PP 2－36 ，Asn30]PP 2－36 ，[Gln30]PP 2－36 ，[Glu10]PP 2－36 ，[Glu10，Leu17，Thr30]PP 2－36 ，[Nle17，Nle30]PP 2－36 ，[Glu10，Nle17，Nle30]PP 2－36 ，它们的PP 1－36 等价物，以及它们的类似物和衍生物是相对于Y1和Y2受体的Y4受体选择性激动剂，可用于治疗肥胖症或超重，认为肥胖或超重是致病因素的疾病，以及腹泻和肠液分泌过多。

USPTO Abstract

本说明书中所述的选自下组的Y4受体激动剂肽：[Ala30]PP 2－36 ，[Thr30]PP 2－36 ，Asn30]PP 2－36 ，[Gln30]PP 2－36 ，[Glu10]PP 2－36 ，[Glu10，Leu17，Thr30]PP 2－36 ，[Nle17，Nle30]PP 2－36 ，[Glu10，Nle17，Nle30]PP 2－36 ，它们的PP 1－36 等价物，以及它们的类似物和衍生物是相对于Y1和Y2受体的Y4受体选择性激动剂，可用于治疗肥胖症或超重，认为肥胖或超重是致病因素的疾病，以及腹泻和肠液分泌过多。

Drugs covered by this patent

Patent Metadata

Patent number
CN101268099A
Jurisdiction
CN
Classification
—
Expires
2008-09-17
Drug substance claim
No
Drug product claim
No
Assignee
7TM Pharma AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.